Bio Vitos Pharma Past Earnings Performance
Past criteria checks 0/6
Bio Vitos Pharma's earnings have been declining at an average annual rate of -17.5%, while the Medical Equipment industry saw earnings growing at 6.3% annually. Revenues have been declining at an average rate of 3.3% per year.
Key information
-17.5%
Earnings growth rate
-2.3%
EPS growth rate
| Medical Equipment Industry Growth | 6.2% |
| Revenue growth rate | -3.3% |
| Return on equity | -39.1% |
| Net Margin | -429.5% |
| Last Earnings Update | 31 Dec 2023 |
Revenue & Expenses BreakdownBeta
How Bio Vitos Pharma makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 3 | -13 | 5 | 0 |
| 30 Sep 23 | 3 | -11 | 5 | 0 |
| 30 Jun 23 | 4 | -11 | 7 | 0 |
| 31 Mar 23 | 4 | -14 | 10 | 0 |
| 31 Dec 22 | 5 | -15 | 11 | 0 |
| 30 Sep 22 | 4 | -15 | 12 | 0 |
| 30 Jun 22 | 4 | -15 | 11 | 0 |
| 31 Mar 22 | 4 | -14 | 11 | 0 |
| 31 Dec 21 | 4 | -14 | 11 | 0 |
| 30 Sep 21 | 3 | -14 | 10 | 0 |
| 30 Jun 21 | 3 | -13 | 10 | 0 |
| 31 Mar 21 | 3 | -13 | 9 | 0 |
| 31 Dec 20 | 3 | -12 | 9 | 0 |
| 30 Sep 20 | 3 | -10 | 9 | 0 |
| 30 Jun 20 | 4 | -9 | 12 | 0 |
| 31 Mar 20 | 5 | -7 | 11 | 0 |
| 31 Dec 19 | 5 | -6 | 10 | 0 |
| 30 Sep 19 | 5 | -6 | 10 | 0 |
| 30 Jun 19 | 4 | -6 | 6 | 0 |
| 31 Mar 19 | 4 | -5 | 6 | 0 |
| 31 Dec 18 | 4 | -5 | 6 | 0 |
| 30 Sep 18 | 4 | -5 | 5 | 0 |
| 30 Jun 18 | 4 | -5 | 4 | 0 |
| 31 Mar 18 | 3 | -5 | 4 | 0 |
| 31 Dec 17 | 3 | -5 | 4 | 0 |
| 30 Sep 17 | 3 | -5 | 4 | 0 |
| 30 Jun 17 | 3 | -5 | 3 | 0 |
| 31 Mar 17 | 2 | -4 | 3 | 0 |
| 31 Dec 16 | 2 | -2 | 2 | 0 |
| 31 Dec 15 | 0 | -2 | 1 | 0 |
| 31 Dec 14 | 0 | -2 | 1 | 0 |
Quality Earnings: BIOVIT is currently unprofitable.
Growing Profit Margin: BIOVIT is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: BIOVIT is unprofitable, and losses have increased over the past 5 years at a rate of 17.5% per year.
Accelerating Growth: Unable to compare BIOVIT's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: BIOVIT is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (59.4%).
Return on Equity
High ROE: BIOVIT has a negative Return on Equity (-39.1%), as it is currently unprofitable.